398 related articles for article (PubMed ID: 26478441)
1. Targeting transcription factor STAT3 for cancer prevention and therapy.
Chai EZ; Shanmugam MK; Arfuso F; Dharmarajan A; Wang C; Kumar AP; Samy RP; Lim LH; Wang L; Goh BC; Ahn KS; Hui KM; Sethi G
Pharmacol Ther; 2016 Jun; 162():86-97. PubMed ID: 26478441
[TBL] [Abstract][Full Text] [Related]
2. Highlighted STAT3 as a potential drug target for cancer therapy.
Lee H; Jeong AJ; Ye SK
BMB Rep; 2019 Jul; 52(7):415-423. PubMed ID: 31186087
[TBL] [Abstract][Full Text] [Related]
3. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy.
Germain D; Frank DA
Clin Cancer Res; 2007 Oct; 13(19):5665-9. PubMed ID: 17908954
[TBL] [Abstract][Full Text] [Related]
4. Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment.
Kim BH; Yi EH; Ye SK
Arch Pharm Res; 2016 Aug; 39(8):1085-99. PubMed ID: 27515050
[TBL] [Abstract][Full Text] [Related]
5. STAT proteins: novel molecular targets for cancer drug discovery.
Turkson J; Jove R
Oncogene; 2000 Dec; 19(56):6613-26. PubMed ID: 11426647
[TBL] [Abstract][Full Text] [Related]
6. Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs.
Klampfer L
Curr Cancer Drug Targets; 2006 Mar; 6(2):107-21. PubMed ID: 16529541
[TBL] [Abstract][Full Text] [Related]
7. Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapy.
Masciocchi D; Gelain A; Villa S; Meneghetti F; Barlocco D
Future Med Chem; 2011 Apr; 3(5):567-97. PubMed ID: 21526897
[TBL] [Abstract][Full Text] [Related]
8. Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer.
Mali SB
Oral Oncol; 2015 Jun; 51(6):565-9. PubMed ID: 25817923
[TBL] [Abstract][Full Text] [Related]
9. Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors.
Siveen KS; Sikka S; Surana R; Dai X; Zhang J; Kumar AP; Tan BK; Sethi G; Bishayee A
Biochim Biophys Acta; 2014 Apr; 1845(2):136-54. PubMed ID: 24388873
[TBL] [Abstract][Full Text] [Related]
10. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution.
Aggarwal BB; Sethi G; Ahn KS; Sandur SK; Pandey MK; Kunnumakkara AB; Sung B; Ichikawa H
Ann N Y Acad Sci; 2006 Dec; 1091():151-69. PubMed ID: 17341611
[TBL] [Abstract][Full Text] [Related]
11. Strategies and Approaches of Targeting STAT3 for Cancer Treatment.
Furtek SL; Backos DS; Matheson CJ; Reigan P
ACS Chem Biol; 2016 Feb; 11(2):308-18. PubMed ID: 26730496
[TBL] [Abstract][Full Text] [Related]
12. Potential role for STAT3 inhibitors in glioblastoma.
Jackson C; Ruzevick J; Amin AG; Lim M
Neurosurg Clin N Am; 2012 Jul; 23(3):379-89. PubMed ID: 22748651
[TBL] [Abstract][Full Text] [Related]
13. STAT3: A Potential Drug Target for Tumor and Inflammation.
Hu YS; Han X; Liu XH
Curr Top Med Chem; 2019; 19(15):1305-1317. PubMed ID: 31218960
[TBL] [Abstract][Full Text] [Related]
14. STAT-3 inhibitors: state of the art and new horizons for cancer treatment.
Lavecchia A; Di Giovanni C; Novellino E
Curr Med Chem; 2011; 18(16):2359-75. PubMed ID: 21568920
[TBL] [Abstract][Full Text] [Related]
15. STAT3 the oncogene - still eluding therapy?
Wake MS; Watson CJ
FEBS J; 2015 Jul; 282(14):2600-11. PubMed ID: 25825152
[TBL] [Abstract][Full Text] [Related]
16. Identification of Lead Compounds as Inhibitors of STAT3: Design, Synthesis and Bioactivity.
Botta A; Sirignano E; Popolo A; Saturnino C; Terracciano S; Foglia A; Sinicropi MS; Longo P; Di Micco S
Mol Inform; 2015 Oct; 34(10):689-97. PubMed ID: 27490969
[TBL] [Abstract][Full Text] [Related]
17. The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy.
Tolomeo M; Cascio A
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435349
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the signal transducers and activators of transcription (STAT) 3 signalling pathway by AG490 in laryngeal carcinoma cells.
Zhang H; Zhang D; Luan X; Xie G; Pan X
J Int Med Res; 2010; 38(5):1673-81. PubMed ID: 21309481
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibitors of STAT3 for cancer therapy.
Zhao M; Jiang B; Gao FH
Curr Med Chem; 2011; 18(26):4012-8. PubMed ID: 21824090
[TBL] [Abstract][Full Text] [Related]
20. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
Buettner R; Mora LB; Jove R
Clin Cancer Res; 2002 Apr; 8(4):945-54. PubMed ID: 11948098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
